378 related articles for article (PubMed ID: 21636702)
41. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.
Toiyama Y; Okugawa Y; Tanaka K; Araki T; Uchida K; Hishida A; Uchino M; Ikeuchi H; Hirota S; Kusunoki M; Boland CR; Goel A
Gastroenterology; 2017 Dec; 153(6):1634-1646.e8. PubMed ID: 28847750
[TBL] [Abstract][Full Text] [Related]
42. Methylated eyes absent 4 (EYA4) gene promotor in non-neoplastic mucosa of ulcerative colitis patients with colorectal cancer: evidence for a field effect.
Kisiel JB; Garrity-Park MM; Taylor WR; Smyrk TC; Ahlquist DA
Inflamm Bowel Dis; 2013 Sep; 19(10):2079-83. PubMed ID: 23867875
[TBL] [Abstract][Full Text] [Related]
43. Investigation of GHSR and GHRL methylation in colorectal cancer.
Coppedè F; Stoccoro A; Lazzarotti A; Spisni R; Migliore L
Epigenomics; 2018 Dec; 10(12):1525-1539. PubMed ID: 29963901
[TBL] [Abstract][Full Text] [Related]
44. Promoter hypermethylation of GALR1 acts as an early epigenetic susceptibility event in colorectal carcinogenesis.
Gu S; Qian S; Lin S; Ye D; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Chen K; Jin M
J Hum Genet; 2022 Sep; 67(9):519-525. PubMed ID: 35606503
[TBL] [Abstract][Full Text] [Related]
45. Promoter Hypermethylation of the Eyes Absent 4 Gene is a Tumor-Specific Epigenetic Biomarker in Iranian Colorectal Cancer Patients.
Barati Bagerabad M; Tavakolian S; Abbaszadegan MR; Kerachian MA
Acta Med Iran; 2018 Jan; 56(1):21-27. PubMed ID: 29436791
[TBL] [Abstract][Full Text] [Related]
46. Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas.
Lind GE; Danielsen SA; Ahlquist T; Merok MA; Andresen K; Skotheim RI; Hektoen M; Rognum TO; Meling GI; Hoff G; Bretthauer M; Thiis-Evensen E; Nesbakken A; Lothe RA
Mol Cancer; 2011 Jul; 10():85. PubMed ID: 21777459
[TBL] [Abstract][Full Text] [Related]
47. Detection of hypermethylated vimentin in urine of patients with colorectal cancer.
Song BP; Jain S; Lin SY; Chen Q; Block TM; Song W; Brenner DE; Su YH
J Mol Diagn; 2012; 14(2):112-9. PubMed ID: 22251609
[TBL] [Abstract][Full Text] [Related]
48. Intermediate- and low-methylation epigenotypes do not correspond to CpG island methylator phenotype (low and -zero) in colorectal cancer.
Karpinski P; Walter M; Szmida E; Ramsey D; Misiak B; Kozlowska J; Bebenek M; Grzebieniak Z; Blin N; Laczmanski L; Sasiadek MM
Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):201-8. PubMed ID: 23175427
[TBL] [Abstract][Full Text] [Related]
49. GPNMB methylation: a new marker of potentially carcinogenic colon lesions.
Ashktorab H; Rahi H; Nouraie M; Shokrani B; Lee E; Haydari T; Laiyemo AO; Siegel P; Brim H
BMC Cancer; 2018 Nov; 18(1):1068. PubMed ID: 30400781
[TBL] [Abstract][Full Text] [Related]
50. Identification of DNA methylation markers for early detection of CRC indicates a role for nervous system-related genes in CRC.
Rademakers G; Massen M; Koch A; Draht MX; Buekers N; Wouters KAD; Vaes N; De Meyer T; Carvalho B; Meijer GA; Herman JG; Smits KM; van Engeland M; Melotte V
Clin Epigenetics; 2021 Apr; 13(1):80. PubMed ID: 33858496
[TBL] [Abstract][Full Text] [Related]
51. MicroRNA and targeted mRNA expression profiling analysis in human colorectal adenomas and adenocarcinomas.
Gattolliat CH; Uguen A; Pesson M; Trillet K; Simon B; Doucet L; Robaszkiewicz M; Corcos L
Eur J Cancer; 2015 Feb; 51(3):409-20. PubMed ID: 25586944
[TBL] [Abstract][Full Text] [Related]
52. Altered regulation of DNA ligase IV activity by aberrant promoter DNA methylation and gene amplification in colorectal cancer.
Kuhmann C; Li C; Kloor M; Salou M; Weigel C; Schmidt CR; Ng LW; Tsui WW; Leung SY; Yuen ST; Becker N; Weichenhan D; Plass C; Schmezer P; Chan TL; Popanda O
Hum Mol Genet; 2014 Apr; 23(8):2043-54. PubMed ID: 24282031
[TBL] [Abstract][Full Text] [Related]
53. A novel method for early detection of colorectal cancer based on detection of methylation of two fragments of syndecan-2 (SDC2) in stool DNA.
Ma L; Qin G; Gai F; Jiang Y; Huang Z; Yang H; Yao S; Du S; Cao Y
BMC Gastroenterol; 2022 Apr; 22(1):191. PubMed ID: 35436855
[TBL] [Abstract][Full Text] [Related]
54. Correlation between hypermethylation of the RASSF2A promoter and K-ras/BRAF mutations in microsatellite-stable colorectal cancers.
Park HW; Kang HC; Kim IJ; Jang SG; Kim K; Yoon HJ; Jeong SY; Park JG
Int J Cancer; 2007 Jan; 120(1):7-12. PubMed ID: 17013898
[TBL] [Abstract][Full Text] [Related]
55. Combined SEPT9 and BMP3 methylation in plasma for colorectal cancer early detection and screening in a Brazilian population.
Lima AB; Dos Reis MB; Matsushita M; Dos Reis MT; de Oliveira MA; Reis RM; Guimarães DP
Cancer Med; 2023 Aug; 12(15):15854-15867. PubMed ID: 37338022
[TBL] [Abstract][Full Text] [Related]
56. Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer.
Wang Q; Huang Z; Ni S; Xiao X; Xu Q; Wang L; Huang D; Tan C; Sheng W; Du X
PLoS One; 2012; 7(9):e44398. PubMed ID: 22970209
[TBL] [Abstract][Full Text] [Related]
57. Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis.
Umetani N; Takeuchi H; Fujimoto A; Shinozaki M; Bilchik AJ; Hoon DS
Clin Cancer Res; 2004 Nov; 10(22):7475-83. PubMed ID: 15569977
[TBL] [Abstract][Full Text] [Related]
58. The Differential DNA Hypermethylation Patterns of microRNA-137 and microRNA-342 Locus in Early Colorectal Lesions and Tumours.
Kashani E; Hadizadeh M; Chaleshi V; Mirfakhraie R; Young C; Savabkar S; Irani S; Asadzadeh Aghdaei H; Ashrafian Bonab M
Biomolecules; 2019 Sep; 9(10):. PubMed ID: 31546665
[TBL] [Abstract][Full Text] [Related]
59. Colorectal cancer early methylation alterations affect the crosstalk between cell and surrounding environment, tracing a biomarker signature specific for this tumor.
Fadda A; Gentilini D; Moi L; Barault L; Leoni VP; Sulas P; Zorcolo L; Restivo A; Cabras F; Fortunato F; Zavattari C; Varesco L; Gismondi V; De Miglio MR; Scanu AM; Colombi F; Lombardi P; Sarotto I; Loi E; Leone F; Giordano S; Di Nicolantonio F; Columbano A; Zavattari P
Int J Cancer; 2018 Aug; 143(4):907-920. PubMed ID: 29542109
[TBL] [Abstract][Full Text] [Related]
60. Diagnostic Assessment of septin9 DNA Methylation for Colorectal Cancer Using Blood Detection: A Meta-Analysis.
Sun G; Meng J; Duan H; Zhang D; Tang Y
Pathol Oncol Res; 2019 Oct; 25(4):1525-1534. PubMed ID: 30488278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
